2C-C

Revision as of 10:50, 14 November 2014 by >Josikins (Distortions)

Template:Proofread 2C-C (2,5-Dimethoxy-4-chlorophenethylamine) is a psychedelic phenethylamine of the 2C-x family.[1] It was first synthesized by Alexander Shulgin and described in his 1991 book PiHKAL: A Chemical Love Story.

2C-C
Chemical Nomenclature
Common names 2C-C
Substitutive name 4-Chloro-2,5-dimethoxyphenethylamine
Systematic name 1-(4-Chloro-2,5-dimethoxyphenyl)-2-aminoethane
Class Membership
Psychoactive class Psychedelic
Chemical class Phenethylamine
Routes of Administration

WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. See responsible use section.



Oral
Dosage
Threshold 5 mg
Light 15 - 30 mg
Common 30 - 50 mg
Strong 50 - 90 mg
Heavy 90 mg +
Duration
Total 4 - 8 hours
Onset 20 - 45 minutes
Come up 45 - 90 minutes
Peak 2 - 3 hours
Offset 1 - 3 hours
After effects 4 - 12 hours









DISCLAIMER: PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy.

Interactions

In modern times it is used as a recreational drug and an entheogen, rarely sold on the streets and almost exclusively obtained as a grey area research chemical through the use of online vendors. Therefore it is relatively uncommon and has only a short history of human use.

Many users report that 2C-C is gentler and more sedating than other closely related psychedelic phenethylamines.

Chemistry

2C-C is a substituted phenethylamine with methoxy groups attached to carbons R2 and R5 as well as a chlorine attached to carbon R4.

Pharmacology

2C-C's psychedelic effects are believed to come from its efficacy at the 5-HT2A receptor as a partial agonist. However, the role of these interactions and how they result in the psychedelic experience continues to remain elusive.

Subjective effects

 
This subjective effects section is a stub.

As such, it is still in progress and may contain incomplete or wrong information.

You can help by expanding or correcting it.

  • soft tingly still all encompassing consistent warm mild mild in comprison to 2cb/e/i
  • dishinibition
  • mild visual disconnection
  • ego suppression
  • enhancement of colour
  • visual supression
  • visual disconnection
  • thought suppression
  • motor control suppression
  • disconnective visual / cognitive
  • entactogenic effects
  • intricate abstract organic unstructured brightly lit multicolored glossy shading equal in soft / sharp edges large in size fast in movement consistent 8b over 8a

The effects listed below are based upon the subjective effects index and personal experiences of PsychonautWiki contributors. The listed effects will rarely if ever occur all at once but heavier dosages will increase the chances and are more likely to induce a full range of effects.

Physical effects

The physical effects of 2C-C can be broken down into four components all of which progressively intensify proportional to dosage. These are described below and generally include:

  • Spontaneous tactile sensations - The "body high" of 2C-C can be described as a pleasurable, warm, soft, all-encompassing and mild tingling sensation. This maintains a consistent presence that steadily rises with the onset and hits its limit once the peak has been reached.
  • Stimulation and Sedation - In terms of its effects on the physical energy levels of the tripper, the 2C-C experience begins with mild stimulation but usually becomes very sedating as the experience progresses and lacks the distinctive energetic feeling associated with most phenethylamines. This feeling was accurately described by Alexander Shulgin as "an intense form of relaxation".[2]
  • Nausea - Although nausea remains present, in comparison to other phenethylamines such as 2C-E, 2C-I or even 2C-B this remains extremely mild and dissipates quickly even with higher dosages. It is perhaps one of the most physically underwhelming psychedelics out there for this reason alone.
  • Bodily control enhancement
  • Tactile enhancement
  • Temperature regulation loss

Cognitive effects

The head space of 2C-C is described by many as one which is both insightful and relatively normal in its thought processes even at moderate to high dosages.

The total sum of these cognitive components regardless of the setting generally includes:

Visual effects

Enhancements

2C-C presents a full and complete array of possible visual enhancements which generally includes:

Distortions

2C-C presents a full and complete array of possible visual distortions which generally includes:

The visual geometry that is present throughout this trip can be described as more similar in appearance to that of 4-AcO-DMT or Ayahuasca than that of LSD, 2C-B or 2C-I. They can be comprehensively described as structured in their organization, organic in geometric style, intricate in complexity, large in size, fast and smooth in motion, colourful in scheme, glossy in colour, sharp in their edges and equally rounded and angular in their corners. They give off a contradictory natural and synthetic feel to them that at higher dosages are significantly more likely to result in states of Level 8B visual geometry over Level 8A.

Hallucinatory states

2C-C produces a full range of high level hallucinatory states in a fashion that is more consistent and reproducible than that of many other commonly used psychedelics. This holds particularly true in comparison to other substances within the phenethylamine family. These effects include:

  • External hallucinations
  • Internal hallucinations - In comparison to other psychedelics such as LSD, 2C-C is extremely high in hallucinations embedded within visual geometry. This particular effect commonly contains hallucinations with scenarios, settings, concepts and autonomous entity contact. They are more common within dark environments and can be described as internal in their manifestation, lucid in believability, interactive in style and almost exclusively of religious, spiritual, mystical or a transcendental nature in their overall theme.

Auditory effects

The auditory effects of 2C-C are common in their occurrence and exhibit a full range of effects which commonly include:

Toxicity and Harm Potential

Lethal Dosage

The toxicity and long term health effects of recreational 2C-C use does not seem to have been studied in any scientific context and the median lethal dose (LD50) is unknown. This is because 2C-C is a research chemical with very little history of human usage. Anecdotal evidence from those who have used 2C-C would suggest that there are little to no immediate or short-term negative health effects attributed to simply trying the drug at low to moderate doses or using it very sparingly. The validity of these statements however, cannot be confirmed.

Tolerance and Addiction Potential

The addictive potential of 2C-C has not yet been formally studied, but anecdotal evidence would suggest that 2C-C is not physically addictive. Many users describe a self-regulating quality; and users commonly report a tolerance build up when used consecutively many days in a row. A build up in tolerance may lead to weakened effects and a diminished experience, however, this effect is nearly non-existent when consumption periods are spaced 5-7 days apart.

Legal Issues

  • United States: 2C-C is listed in schedule I of section 202(c) of the Controlled Substances Act in the United States, signed into law as of July, 2012 under the Food and Drug Administration Safety and Innovation Act.[3]
  • United Kingdom: 2C-C is a class A controlled substance as it is covered by the phenethylamine derivatives clause of the Misuse of Drugs Act 1971.
  • Sweden: 2C-C is classified as "health hazard" as of March 1, 2005 in their regulation SFS 2005:26, making it illegal to sell or possess.[4]
  • Japan: 2C-C is controlled by the Pharmaceutical Affairs Law in Japan, making it illegal to possess or sell. [5]
  • Australia: Australia has a blanket ban over all substituted phenethylamines including the entire 2C-X family[6]

See Also

References

  1. Alexander Shulgin - PIHKAL | http://www.erowid.org/library/books_online/pihkal/pihkal033.shtml
  2. http://www.erowid.org/library/books_online/pihkal/pihkal022.shtml
  3. S. 3187: Food and Drug Administration Safety and Innovation Act, Subtitle D-Synthetic Drugs | http://www.govtrack.us/congress/bills/112/s3187/text
  4. Svensk författningssamling | http://www.notisum.se/rnp/sls/sfs/20050026.pdf
  5. Analytical Data of Designated Substances (Shitei-Yakubutsu) Controlled by the Pharmaceutical AŠairs Law in Japan, Part I: GC-MS and LC-MS | https://www.erowid.org/references/texts/show/7395docid7635
  6. New Psychoactive Substances (National Drug and Alcohol Research Centre 2014) | https://comorbidity.edu.au/sites/default/files/cre/page/New%20Psychoactive%20Substances.pdf